Eiko Lifesciences has disclosed the voting results for its 49th Annual General Meeting held on September 22, 2026. All four resolutions proposed by the Board were passed with the requisite majority, including the adoption of FY26 financial statements and the appointment of Suraj Mahadev Gaikwad as an Independent Director.

The meeting was conducted via video conferencing in compliance with the Companies Act, 2013 and SEBI regulations. The scrutinizer's report, submitted by Shravan A. Gupta & Associates, confirmed that remote e-voting and e-voting during the AGM yielded valid results for all agenda items. Notably, promoter and promoter group votes were excluded from specific resolutions where they were deemed interested parties.

Voting results summary

The following table summarizes the voting outcome for each resolution passed during the meeting:

Note: For Resolutions 2 and 4, promoter votes totalling 57,24,788 were treated as invalid as they are interested parties.

Board composition and attendance

The meeting was attended by 25 members through video conferencing or other audio-visual means. The requisite quorum was present at the beginning and throughout the session. Key managerial personnel and directors participated in the proceedings.

Resolutions passed

The following items of business were transacted during the meeting:

• Adoption of Financial Statements: Ordinary resolution to receive, consider, and adopt the Audited Standalone and Consolidated Financial Statements for FY26, along with the Reports of the Board of Directors and Auditors.
• Re-appointment of Director: Ordinary resolution to re-appoint Bhavesh Dhirajlal Tanna (DIN: 03353445) as a Director liable to retire by rotation.
• Appointment of Independent Director: Special resolution to appoint Suraj Mahadev Gaikwad (DIN: 11159369) as an Independent Director.
• Related Party Transactions: Ordinary resolution to approve material related party transactions entered into or proposed to be entered into with related parties.

Proceedings summary

Chairman Laxmikant Kabra addressed the shareholders, sharing the company's vision and highlighting areas where the company may see exciting opportunities. The floor was opened for questions and answers, allowing shareholders to share their views. The Chairperson proposed a vote of thanks to the members, directors, auditors, and management before concluding the meeting at 4:54 pm IST.

The statutory auditor, M/s P S V Jain & Associates, Chartered Accountants, and the secretarial auditor, M/s Shravan A. Gupta & Associates, were present via video conferencing. The scrutiniser's representative also attended the meeting.

Eiko Lifesciences has filed its 49th annual report for FY26 and confirmed its annual general meeting is set for September 22, 2026. The filing marks the completion of statutory disclosures for the financial year.

The board meeting held on August 24, 2026, approved these agenda items pursuant to Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The AGM will be conducted via video conferencing or other audio-visual means.

Board Composition Changes

Suraj Mahadev Gaikwad was appointed as an additional independent and non-executive director on August 24, 2026. He will hold office until the ensuing AGM, after which he will serve as an independent director for a five-year term, subject to shareholder approval. Mr. Gaikwad brings over seven years of experience in accountancy and business management and holds a commerce degree.

The board also noted the resignation of independent director Hasti Doshi, effective August 24, 2026, citing other career commitments. Her term was originally scheduled to conclude on September 3, 2029. Additionally, the board recommended the re-appointment of Bhavesh Dhirajlal Tanna as a director liable to retire by rotation. Mr. Tanna, who holds a 5.86% stake in the company, has over 24 years of experience in investment and financial consultancy.

Related-Party Transactions

Shareholders are asked to approve material related-party transactions expected in FY27. These transactions, deemed to be in the ordinary course of business and at arm’s length, involve loans, advances, and operational dealings with promoters, their associates, and subsidiaries.

Promoter group entities holding shares will not vote on this resolution as per Regulation 23(7) of the SEBI Listing Regulations.

Annual General Meeting Details

The 49th AGM is scheduled for Tuesday, September 22, 2026, at 4:00 pm. The meeting venue is deemed to be the registered office at Thane West. Shravan Gupta, a practicing company secretary, was appointed as the scrutinizer to oversee the e-voting process. M/s Bigshare Services Pvt Ltd will serve as the service provider for conducting e-voting and video conferencing facilities.

Remote e-voting will begin on September 19, 2026, at 9:00 am and end on September 21, 2026, at 5:00 pm. Shareholders must hold shares as on the cut-off date of September 16, 2026, to be eligible to vote. Members wishing to speak at the AGM must register by September 18, 2026, at 5:00 pm.